Subsidy Tracker Parent Company Summary
Parent Company Name:
Pfizer
Ownership Structure:
publicly traded (ticker symbol PFE)
Headquartered in:
New York
Major Industry:
pharmaceuticals
Specific Industry:
pharmaceuticals
| Subsidy Summary | Subsidy Value | Number of Awards |
|---|---|---|
| State/Local | $327,574,590 | 204 |
| Federal (grants and allocated tax credits) | $54,408,698 | 29 |
| TOTAL | $381,983,288 | 233 |
| Loan / Bailout Summary | Total Face Value | Number of Awards |
| State/Local loans, bond financing and venture capital | $220,000,000 | 1 |
| Federal loans, loan guarantees and bailout assistance (not including repayments) | $0 | 0 |
| TOTAL | $220,000,000 | 1 |
Time Period for State and Local Awards:
Earliest year of data: 1992. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2009.
Time Period for Federal Awards:
FY2000 to the present
Notes:
Dollar totals do not include awards for which no subsidy value is disclosed.
Links:
For a summary of this company's regulatory violations see its Violation Tracker summary page here.
For an overview of this company's accountability track record, read its Corporate Rap Sheet here.
For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.
For an overview of political contributions associated with this company, see its Follow the Money page.
| Top 5 States for state/local awards | Total Subsidy $ | Number of Awards |
|---|---|---|
| Michigan | $85,200,000 | 2 |
| Connecticut | $60,000,000 | 1 |
| North Carolina | $55,518,165 | 88 |
| New York | $44,472,079 | 26 |
| New Jersey | $38,807,831 | 5 |
| All other | $43,576,515 | 82 |
Individual Subsidy Records:
Click on the company name for more information on each subsidy award.
Download results as 
or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
| Company | Location | Subsidy Source | Year |
Subsidy Value |
Loan/Bailout Value | Type of Subsidy |
|---|---|---|---|---|---|---|
| Hospira, Inc. | North Carolina | state | 2011 | $344,981 | tax credit/rebate | |
| PFIZER, INC. | Missouri | state | 2000 | $315,055 | tax credit/rebate | |
| Pfizer, Inc. | North Carolina | state | 2017 | $305,389 | tax credit/rebate | |
| WYETH HOLDINGS CORPORATION | New York | local | 2009 | $280,900 | tax credit/rebate; property tax abatement | |
| Hospira, Inc. | North Carolina | state | 2019 | $280,119 | tax credit/rebate | |
| Hospira, Inc. | North Carolina | state | 2016 | $277,903 | tax credit/rebate | |
| Wyeth Holdings Corporation | North Carolina | state | 2013 | $272,967 | tax credit/rebate | |
| Wyeth Holdings Corporation | North Carolina | state | 2013 | $272,967 | tax credit/rebate | |
| EMBREX INC | United States | federal | 2000 | $262,125 | federal grant | |
| Hospira, Inc. | North Carolina | state | 2013 | $261,281 | tax credit/rebate | |
| Hospira, Inc. | North Carolina | state | 2008 | $254,292 | tax credit/rebate | |
| Hospira, Inc. | North Carolina | state | 2011 | $252,000 | tax credit/rebate | |
| BioRexis | Pennsylvania | state | $250,000 | training reimbursement | ||
| Hospira, Inc. | North Carolina | state | 2015 | $240,137 | tax credit/rebate | |
| Pfizer, Inc. | Pennsylvania | state | 2016 | $237,427 | tax credit/rebate | |
| Pfizer Holdings Americas Corporation | North Carolina | state | 2015 | $236,159 | tax credit/rebate | |
| Hospira, Inc. | North Carolina | state | 2013 | $231,735 | tax credit/rebate | |
| PFIZER INC | New York | local | 2012 | $228,420 | property tax abatement | |
| PFIZER INC | New York | local | 2011 | $228,375 | property tax abatement | |
| Wyeth Holdings Corporation | North Carolina | state | 2012 | $218,644 | tax credit/rebate | |
| Wyeth Holdings Corporation | North Carolina | state | 2012 | $218,644 | tax credit/rebate | |
| Hospira, Inc. | North Carolina | state | 2014 | $218,428 | tax credit/rebate | |
| Hospira, Inc. and Subsidiaries | Illinois | state | 2005 | $200,000 | grant | |
| Hospira, Inc. and Subsidiaries | Illinois | state | 2005 | $200,000 | grant | |
| Hospira, Inc. | North Carolina | state | 2008 | $200,000 | tax credit/rebate | |
| Hospira, Inc. and Subsidiaries | Illinois | state | 2005 | $196,965 | grant | |
| Hospira, Inc. and Subsidiaries | Illinois | state | 2005 | $196,965 | grant | |
| Pfizer, Inc. | North Carolina | state | 2010 | $195,448 | tax credit/rebate | |
| Hospira, Inc. | Kansas | state | 2007 | $190,000 | training reimbursement | |
| Wyeth Holdings Corporation | North Carolina | state | 2011 | $189,498 | tax credit/rebate | |
| Pfizer Holdings Americas Corporation | North Carolina | state | 2015 | $187,566 | tax credit/rebate | |
| Pfizer Inc. & Subsidiaries | Maryland | state | 2017 | $183,559 | tax credit/rebate | |
| Wyeth | Pennsylvania | state | 2009 | $154,958 | tax credit/rebate | |
| ANACOR PHARMACEUTICALS INC | United States | federal | 2011 | $148,361 | federal grant | |
| Pharmacia Corporation | North Carolina | state | 2013 | $145,378 | tax credit/rebate | |
| Pharmacia Corporation | North Carolina | state | 2013 | $145,378 | tax credit/rebate | |
| Wyeth Holdings Corporation | North Carolina | state | 2014 | $143,193 | tax credit/rebate | |
| Wyeth Holdings Corporation | North Carolina | state | 2014 | $143,193 | tax credit/rebate | |
| Pfizer, Inc. | Maryland | state | 2008 | $131,514 | tax credit/rebate | |
| Wyeth Holdings LLC | North Carolina | state | 2019 | $125,000 | grant | |
| Pfizer Corporation | Maryland | state | 2007 | $123,426 | tax credit/rebate | |
| Innopharma Inc. | New Jersey | state | 2009 | $119,831 | grant | |
| Hospira, Inc. | Kansas | state | 2007 | $103,000 | grant | |
| EMBREX INC | United States | federal | 2005 | $102,723 | federal grant | |
| Hospira, Inc. and Subsidiaries | Illinois | state | 2004 | $100,000 | tax credit/rebate | |
| BioRexis Pharmaceutical Corporation | Pennsylvania | state | $100,000 | grant | ||
| EMBREX | United States | federal | 2004 | $99,798 | federal grant | |
| Pfizer Inc. & Subsidiaries | Maryland | state | 2018 | $92,193 | tax credit/rebate | |
| PFIZER INC | Tennessee | local | 2009 | $86,991 | property tax abatement | |
| Hospira, Inc. | North Carolina | state | 2011 | $85,000 | tax credit/rebate | |
| EMBREX INC | United States | federal | 2004 | $80,000 | federal grant | |
| Pfizer, Inc. & Subsidiaries | Maryland | state | 2016 | $79,533 | tax credit/rebate | |
| EMBREX INC | United States | federal | 2001 | $75,500 | federal grant | |
| Pharmacia Corporation | Maryland | state | 2008 | $74,621 | tax credit/rebate | |
| PFIZER INC | Tennessee | local | 2009 | $69,750 | property tax abatement | |
| EMBREX INC | United States | federal | 2000 | $69,375 | federal grant | |
| Hospira, Inc. | Kansas | state | 2006 | $68,770 | training reimbursement | |
| PFIZER INC | Tennessee | local | 2008 | $67,264 | property tax abatement | |
| Pfizer Holdings Americas Corporation | North Carolina | state | 2016 | $66,776 | tax credit/rebate | |
| Embrex, Inc. | North Carolina | state | 2003 | $65,000 | grant | |
| PFIZER INC | Tennessee | local | 2010 | $62,485 | property tax abatement | |
| Embrex, Inc. | North Carolina | state | 2015 | $61,459 | tax credit/rebate | |
| Pfizer Inc. & Subsidiaries | Maryland | state | 2012 | $60,651 | tax credit/rebate | |
| Pfizer Inc. & Subsidiaries | Maryland | state | 2014 | $60,651 | tax credit/rebate | |
| Icagen, Inc. | North Carolina | state | 2015 | $60,444 | tax credit/rebate | |
| Pfizer Inc. | Maryland | state | 2005 | $60,097 | tax credit/rebate | |
| Hospira, Inc. | North Carolina | state | 2014 | $59,897 | tax credit/rebate | |
| EMBREX INC | United States | federal | 2005 | $59,766 | federal grant | |
| PFIZER INC | Tennessee | local | 2011 | $57,012 | property tax abatement | |
| Pfizer, Inc. | Maryland | state | 2009 | $56,291 | tax credit/rebate | |
| Icagen, Inc. | North Carolina | state | 2012 | $54,345 | tax credit/rebate | |
| Icagen, Inc. | North Carolina | state | 2012 | $54,345 | tax credit/rebate | |
| Pfizer Inc. & Subsidiaries | Maryland | state | 2011 | $49,888 | tax credit/rebate | |
| Pfizer Inc & Subsidiaries | Maryland | state | 2019 | $42,853 | tax credit/rebate | |
| Hospira, Inc. | North Carolina | state | 2008 | $33,750 | tax credit/rebate | |
| Pfizer Inc. | Maryland | state | 2004 | $33,734 | tax credit/rebate | |
| Embrex, Inc. | North Carolina | state | 2012 | $32,718 | tax credit/rebate | |
| Embrex, Inc. | North Carolina | state | 2012 | $32,718 | tax credit/rebate | |
| Embrex, Inc. | North Carolina | state | 2013 | $31,549 | tax credit/rebate | |
| Embrex, Inc. | North Carolina | state | 2013 | $31,549 | tax credit/rebate | |
| Hospira Inc. | Colorado | state | 2014 | $31,104 | training reimbursement | |
| PFIZER INC | Tennessee | local | 2012 | $30,865 | property tax abatement | |
| Embrex, Inc. | North Carolina | state | 2005 | $30,772 | grant | |
| Icagen, Inc. | North Carolina | state | 2013 | $29,917 | tax credit/rebate | |
| Icagen, Inc. | North Carolina | state | 2013 | $29,917 | tax credit/rebate | |
| PFIZER INC | Tennessee | local | 2008 | $29,818 | property tax abatement | |
| PFIZER INC | Tennessee | local | 2012 | $27,660 | property tax abatement | |
| Embrex, Inc. | North Carolina | state | 2010 | $27,295 | tax credit/rebate | |
| Icagen, Inc. | North Carolina | state | 2016 | $26,647 | tax credit/rebate | |
| Hospira, Inc. | North Carolina | state | 2016 | $25,455 | tax credit/rebate | |
| Pfizer Research (NC), Inc. | North Carolina | state | 2017 | $25,023 | tax credit/rebate | |
| Serenex, Inc. | North Carolina | state | 2011 | $21,743 | tax credit/rebate | |
| Serenex, Inc. | North Carolina | state | 2010 | $21,507 | tax credit/rebate | |
| Embrex, Inc. | North Carolina | state | 2011 | $21,304 | tax credit/rebate | |
| Pfizer Research (NC), Inc. | North Carolina | state | 2018 | $20,975 | tax credit/rebate | |
| PFIZER | Tennessee | local | 2008 | $20,843 | property tax abatement | |
| Pfizer Research (NC), Inc. | North Carolina | state | 2019 | $20,803 | tax credit/rebate | |
| Pfizer Inc. & Subsidiaries | Maryland | state | 2010 | $18,433 | tax credit/rebate | |
| Embrex, Inc. | North Carolina | state | 2016 | $16,007 | tax credit/rebate | |
| PFIZER INC | Tennessee | local | 2013 | $15,136 | property tax abatement | |
| King Pharmaceuticals Research and Development, Inc | North Carolina | state | 2015 | $15,133 | tax credit/rebate |
Download results as or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
